Africa Oil Corp (TSX:AOI) said it has signed two production-sharing contracts (PSCs) with the Republic of Equatorial Guinea for offshore Blocks EG-18 and EG-31, subject to ratification by the country's government.
Under the PSCs, Africa Oil will hold 80% operated interests in each block with the balance to be held by GEPetrol, the national oil company of Equatorial Guinea. GEPetrol has the option of acquiring an additional 15% participating interest in each block. Both blocks are covered by 3D seismic data and the total minimum work commitment for both blocks in the initial exploration periods is a combined total of US$7 million, with no drilling commitment.
Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) has said its Rio Cravo Este-3 (RCE-3) appraisal well on the Tapir Block in Colombia’s Llanos Basin has reached target depth.
The company noted the RCE-3 well, which is located within the Rio Cravo Este oil field, reached total depth on February 16, 2023. The well was drilled to a total measured depth of 8,880 feet (8,087 feet true vertical depth) and encountered seven hydrocarbon-bearing intervals totaling 58 net feet of oil pay at measured depth, it added.
A UK quantum computing startup developing a cost-effective technology has raised funds from IP Group PLC (LSE:IPO), Octopus Ventures, Bosch, Porsche and the venture arm of the British Business Bank (BBB).
Quantum Motion, which was spun out of University College London, has raised over £42mln as it looks to accelerate its development of silicon quantum processors, with the aim of producing a commercial product by 2030.
A zero-emission air taxi, in which IP Group PLC (LSE:IPO) is a major investor, has completed its maiden flight in Australia.
AMSL Aero’s Vertiia all-electric vertical-takeoff-and-landing (eVTOL) aircraft flew by remote control after taking off from a site in New South Wales.
Communications and internet investor Cordiant Digital Infrastructure Ltd (LSE:CORD)’s Polish portfolio company Emitel has signed an agreement with Polish public broadcaster Telewizja Polska for an expansion of the broadcaster’s transmissions through a new, sixth digital television multiplex called MUX-6.
Emitel has developed the new digital terrestrial television MUX-6 over the past two years around the DVB-T2 technology standard to expand capacity and augment its service offerings for broadcasters.
Early results from of a Scancell Holdings PLC phase I/II cancer study have been described as ‘very encouraging’ by one of the investigators supervising the trial.
So far, the company’s Modi-1 vaccine has been administered to 23 people as part of the ModiFY clinical evaluation of the drug.
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) said it has completed a scoping study for the Zafar underground mine in Azerbaijan. Development work and the construction of two portals has also started.
The study included a review of geotechnical conditions, optimal mining methods and mine scheduling and design.
Pantheon Resources PLC (AIM:PANR, OTC:PTHRF) said it has now restarted flow testing operations at its Alkaid #2 well in Alaska following the cleanout of the sand blockage in the wellbore.
Flow test information will only be reported after flow rates have been stabilized, it added.
Bango PLC (AIM:BGO, OTCQX:BGOPF) has added a new partnership with Dropbox, enabling the cloud storage provider to offer its subscription packages through a global network of telecom operators.
The AIM-listed company's platform allows companies to launch consumer offers through channels such as telecom carrier billing, digital wallets and subscription bundling.
Atlantic Lithium Limited (AIM:ALL, OTCQX:ALLIF, ASX:A11) in a statement notified investors it will be attending a number of upcoming conferences in the month of March including events in London, Canada, and Australia.
OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) told investors that its chief executive Gary Jacob, Ph.D, will give an oral presentation entitled: "A Lipidated Protease-Resistant Chemerin Peptide Offers a Novel Therapeutic for Dry Eyes" on February 22 at the GPCRs-Targeted Drug Discovery Summit at the Hyatt Regency in Boston. Further details about the event and co-presenters were provided in a statement.